TagsHaematology 
ANAGRELIDE SANDOZ®

ANAGRELIDE SANDOZ® (Anagrelide hydrochloride) NOVARTIS HK Reg. No. HK-68231 Composition: 2 ANAGRELIDE SANDOZ® (anagrelide hydrochloride) is an inhibitor of cyclic AMP phosphodiesterase III. It is available in 0.5 mg hard capsule. Indication:...

Oct 22, 2024
TARGRETIN™

TARGRETIN™ (bexarotene) MAIN LIFE HK Reg. No. HK-68294 (04 Jul, 2024) Composition: 1 Targretin™ (bexarotene) is a member of a subclass of retinoids that selectively activate retinoid X receptors (RXRs). Targretin™ is available in c...

Aug 20, 2024
The Unmet Needs in Relapse/ Refractory Multiple Myeloma: A Clinical Challenge

Multiple myeloma (MM) is a haematologic malignancy characterised by abnormal clonal plasma cells in the bone marrow with a potential for uncontrolled growth causing destruction, osseous lesion, acute kidney injury (AKI), anaemia, and hypercalcaemia....

Aug 20, 2024
Is Gene Therapy or Bioartificial Organs the Future of Medical Treatment?

Rare diseases typically have a prevalence below 0.05% and constitute around 10,000 diseases, cumulatively affecting over 5% of the global population. Although there is a large unmet need in treatment, the recent advent of gene therapy is beginning t...

Aug 20, 2024
Overcoming the TP53 Mutated AML Treatment Dilemma

Tumour protein 53 (TP53) gene is located on the chromosome 17 that encodes for the p53 protein, which is a tumour suppressor protein with 393 amino acid responsible for regulating cellular stress 1 . Notably, TP53 can be inactivated directly due to ...

Apr 18, 2024
COLUMVI

COLUMVI (glofitamab-gxbm) ROCHE Indications: COLUMVI is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) or large B-cell lymphoma (LBCL) arising from foll...

Feb 6, 2024
A New Cornerstone in AL Amyloidosis Treatment

AL Amyloidosis: A Rare but Multifaceted Disease Light chain (AL) amyloidosis is a rare multi-systemic, incurable protein misfolding disorder characterised by plasma cell dyscrasia and abnormal clonal plasma cell proliferation 1 . Immunoglobulin secr...

Feb 6, 2024
Adynovate

Adynovate (rurioctocog alfa pegol) Takeda Composition: Adynovate 250 and 500 International Units (IU). Adynovate [rurioctocog alfa pegol, Recombinant Coagulation Factor VIII (rch), PEGylated] is supplied in single-use vials containing nominal poten...

Dec 18, 2023
Exkivity

Exkivity® ( mobocertinib ) 1-3 Takeda Mobocertinib is a kinase inhibitor of the epidermal growth factor receptor (EGFR) that selectively inhibits and irreversibly binds to EGFR exon 20 insertion mutations at lower concentrations than Wild type (...

Jun 13, 2023
Maintain Physically Active After Stroke for Better Recovery

The health benefits of physical activity are undeniable, especially in reducing the risk of cardiovascular diseases and various cancers. More than the prevention of ill health, being physical active indeed promotes better functional capacity and rec...

Jun 13, 2023
Cancer Cells Use Uridine-derived Ribose as Fuel when Starved

Pancreatic ductal adenocarcinoma (PDA) is called a silent killer, as it is often discovered late and has a high mortality rate. Its treatment-resistant and aggressive nature can be attributed to the tumour microenvironment, low vascularity, and meta...

Jun 13, 2023
POEMS Syndrome – A Rare and Challenging Disorder

The POEMS syndrome is a rare plasma cell disorder involving pathological changes of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes. The diagnostic and therapeutic management of the disease is clinically challenging. Given ...

Jun 13, 2023